Efficacy and safety of apremilast in patients with moderate plaque psoriasis with lower BSA (UNVEIL phase 4 study)

Authors
Category Primary study
JournalJournal of Clinical and Aesthetic Dermatology
Year 2017
This article has no abstract
Epistemonikos ID: 40d6781a7d4eb83f9e98542b9512fd09cdbe4c2b
First added on: Feb 09, 2025